Access our capabilities and expertise—and reduce your risk
Your drug development process can be delayed or derailed by any number of challenges and unexpected issues. When you partner with SPI Pharma, you gain access to the full capabilities and resources of a global leader with a solid track record of success. We understand how to proactively identify and address problems before they impact your program milestones.
We serve more than 55 countries with functional excipients, drug delivery systems for tablets, fast-dissolve and taste-masking technologies, chewables, lozenges, and a variety of other patient-friendly dosage formats.
SPI Pharma also specializes in drug development services, delivering in-vitro data packages in CTD Module 3.2 format.
Our unique orally disintegrating tablet (ODT) platform, Pharmaburst®, was the first direct compression offering on the market. It is a tried and tested solution you can rely on to meet your needs, no matter how complex your formulation challenges may be. To date, Pharmaburst has been used in nearly 60 products around the world. That experience enables us to simplify your formulation and manufacturing process while streamlining your path to market.
With expertise in global regulatory requirements across more than 55 countries, SPI Pharma can ensure that your products and processes comply with all relevant standards and regulations.
Find out more about our unique ODT technology—and how it can help you increase your market share in the orally disintegrating tablet marketplace.